#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fibrosarcoma Waldenstrom's macroglobulinaemia refractory B-cell type acute leukaemia Cutaneous T-cell lymphoma recurrent Von Willebrand's disease Neuromyelitis optica spectrum disorder Anal cancer recurrent Pulmonary hypertension Alport's syndrome Chronic lymphocytic leukaemia recurrent Cryoglobulinaemia Hyperphagia Glioblastoma Synovial sarcoma Glycogen storage disease type II More trials…

    Learn about Rare Diseases

    Sarcoma Ornithine transcarbamoylase deficiency – Life with Disease Mucopolysaccharidosis II – Diagnostics CADASIL Glomerulonephritis membranous – Diagnostics Antisynthetase syndrome – Treatment Atypical teratoid/rhabdoid tumour of CNS – Treatment Nephrotic syndrome – Life with Disease Metachromatic leukodystrophy – Life with Disease Glomerulonephritis membranous – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Keto-Isoleucine Calcium Cagrilintide GSKVX000000030918 Cldn6 Car-T Mirikizumab Liraglutide BENZYDAMINE HYDROCHLORIDE Perindopril Tert-Butylamine Aripiprazole DUVELISIB Verapamil Hydrochloride Ivonescimab GSKVX000000030825 Diacerein SGT-003 Rhh646 Tropicamide Pimecrolimus Avalglucosidase Alfa Encaleret Sulfate More therapies…

    Learn about Your Condition

    Primary hyperoxaluria Malignant melanoma stage II Pyrexia Meningorrhagia Juvenile spondyloarthritis Sepsis Uterine leiomyosarcoma Mantle cell lymphoma stage III Ophthalmoplegia Cholecystitis acute White matter lesion Breast cancer metastatic Frostbite Hypertrophic cardiomyopathy Colorectal cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Pancreatic carcinoma

  • Study on Tislelizumab for Cancer Patients with Molecular Residual Disease After Standard Treatment

    Recruiting

    3 1 1
    Investigated Drugs:
    • Tislelizumab
    • Sodium Chloride
    France

  • Study on Pancreas Removal and Islet Cell Transplant for Patients with Pancreatic Cancer at High Risk of Post-Surgery Leaks

    Recruiting

    2 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    Investigated Drugs:
    • Autologous Pancreatic Islets
    Germany

  • Study on FOLFIRINOX, Pembrolizumab, and SABR for Patients with Borderline Resectable Pancreatic Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    • Pancreatic carcinoma metastatic
    Investigated Drugs:
    • Fluorouracil
    • Folinic Acid
    • Irinotecan Hydrochloride Trihydrate
    The Netherlands

  • Study on the Effects of Histamine Dihydrochloride and Aldesleukin in Patients with Resectable Pancreatic Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    Investigated Drugs:
    • Histamine Dihydrochloride
    • Aldesleukin
    Sweden

  • Study of AZD9574 and Temozolomide for Patients with Advanced Solid Tumors, Including Breast, Ovarian, Pancreatic, and Prostate Cancers

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Metastases to biliary tract
    • Metastases to central nervous system
    • Metastatic glioma
    Investigated Drugs:
    • 6-Fluoro-5-[4-[(5-Fluoro-2-Methyl-3-Oxo-4H-Quinoxalin-6-Yl)Methyl]Piperazin-1-Yl]-N-Methylpyridine-2-Carboxamide
    • [11C]Az14193391
    • Trastuzumab Deruxtecan
    Spain Sweden

  • Study on the Safety and Tolerability of CEB-01 in Patients with Pancreatic Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    Investigated Drugs:
    • 7-Ethyl-10-Hydroxycamptothecin
    Spain
Previous Page
1 … 3 4 5 6 7 … 10
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!